<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: rivaroxaban</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Do blood thinners + stroke treatment = danger? Study indicates the risk is low</title>
   	 <description>Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.</description>
     <link>http://medicalxpress.com/news/2013-03-blood-thinners-treatment-danger.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 13 Mar 2013 10:10:33 EST</pubDate>
	 <guid isPermaLink="false">news282388225</guid>
	 
</item>
<item>
     <title>Rivaroxaban found noninferior to enoxaparin in acutely ill</title>
   	 <description>(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has superior efficacy, according to a study published in the Feb. 7 issue of the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2013-02-rivaroxaban-noninferior-enoxaparin-acutely-ill.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 07 Feb 2013 11:20:02 EST</pubDate>
	 <guid isPermaLink="false">news279457844</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/rivaroxabanf.jpg" width="90" height="90" />
</item>
<item>
     <title>Xarelto's approval expanded</title>
   	 <description>(HealthDay)—Approval of the anti-clotting drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and Drug Administration to include treating deep vein thrombosis (DVT) or pulmonary embolism.</description>
     <link>http://medicalxpress.com/news/2012-11-xarelto.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 05 Nov 2012 18:10:01 EST</pubDate>
	 <guid isPermaLink="false">news271358335</guid>
	 
</item>
<item>
     <title>More GI bleeding seen in atrial fibrillation patients on rivaroxaban than warfarin</title>
   	 <description>Patients with atrial fibrillation (AF) experienced more major and non-major clinically relevant GI bleeding when taking rivaroxaban than patients taking warfarin.</description>
     <link>http://medicalxpress.com/news/2012-10-gi-atrial-fibrillation-patients-rivaroxaban.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 22 Oct 2012 03:59:41 EST</pubDate>
	 <guid isPermaLink="false">news270097176</guid>
	 
</item>
<item>
     <title>New blood thinner may lower chances of clots in high-risk heart patients: FDA</title>
   	 <description>(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.</description>
     <link>http://medicalxpress.com/news/2012-05-blood-thinner-chances-clots-high-risk.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 21 May 2012 21:30:01 EST</pubDate>
	 <guid isPermaLink="false">news256843717</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newbloodthin.jpg" width="90" height="90" />
</item>
<item>
     <title>Stroke risk high when anti-clotting drugs stopped</title>
   	 <description>Some patients with irregular heartbeats who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association's Emerging Science Series webinar.</description>
     <link>http://medicalxpress.com/news/2012-04-high-anti-clotting-drugs.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 25 Apr 2012 13:02:57 EST</pubDate>
	 <guid isPermaLink="false">news254577764</guid>
	 
</item>
<item>
     <title>Rivaroxaban has less risk of brain bleeding in patients at high risk for stroke</title>
   	 <description>For patients with a type of irregular heart beat called atrial fibrillation (AF), a new anti-clotting drug might be better at preventing clot-related strokes while minimizing the risk of causing a bleeding stroke. The research was presented at the American Stroke Association's International Stroke Conference 2012.</description>
     <link>http://medicalxpress.com/news/2012-02-rivaroxaban-brain-patients-high.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 02 Feb 2012 09:35:19 EST</pubDate>
	 <guid isPermaLink="false">news247397706</guid>
	 
</item>
<item>
     <title>Anti-clotting drug lowers risks in acute coronary syndrome treatment</title>
   	 <description>An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.</description>
     <link>http://medicalxpress.com/news/2011-11-anti-clotting-drug-lowers-acute-coronary.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 14 Nov 2011 09:32:56 EST</pubDate>
	 <guid isPermaLink="false">news240485566</guid>
	 
</item>
<item>
     <title>Study shows ability of new agent to prevent strokes in patients with atrial fibrillation</title>
   	 <description>In the primary result from the largest double-blind study ever completed to assess a drug's effect in the prevention of stroke in patients with atrial fibrillation, a common heart rhythm abnormality, rivaroxaban, an anti-clotting drug, was shown to be an attractive alternative to warfarin, the current standard for treatment of atrial fibrillation.</description>
     <link>http://medicalxpress.com/news/2011-08-heart-patients-benefit-drug.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 10 Aug 2011 17:21:26 EST</pubDate>
	 <guid isPermaLink="false">news232215654</guid>
	 
</item>


</channel>
</rss>
